115 related articles for article (PubMed ID: 25105423)
1. An enantiomerically pure formulation of esmolol attenuates hypotension and preserves heart rate control in dogs.
McKee JS; Rabinow BE; Daller JR; Brooks BD; Baumgartner B; Rohatgi P
Anesthesiology; 2014 Dec; 121(6):1184-93. PubMed ID: 25105423
[TBL] [Abstract][Full Text] [Related]
2. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
De Pauw M; Vilaine JP; Heyndrickx GR
Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
[TBL] [Abstract][Full Text] [Related]
3. Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts.
Ikeshita K; Nishikawa K; Toriyama S; Yamashita T; Tani Y; Yamada T; Asada A
J Anesth; 2008; 22(4):361-6. PubMed ID: 19011773
[TBL] [Abstract][Full Text] [Related]
4. Esmolol attenuates hepatic blood flow responses during sodium nitroprusside-induced hypotension in dogs.
Takeda S; Masuda R; Kanazawa T; Tomaru T
Can J Anaesth; 2004 Apr; 51(4):348-53. PubMed ID: 15064263
[TBL] [Abstract][Full Text] [Related]
5. Esmolol for potentiation of nitroprusside-induced hypotension: impact on the cardiovascular, adrenergic, and renin-angiotensin systems in man.
Edmondson R; Del Valle O; Shah N; Wong G; Dwyer D; Matarazzo D; Thorne A; Coffey C; Bedford R
Anesth Analg; 1989 Aug; 69(2):202-6. PubMed ID: 2569849
[TBL] [Abstract][Full Text] [Related]
6. The effects of esmolol and dexmedetomidine on myocardial oxygen consumption during sympathetic stimulation in dogs.
Willigers HM; Prinzen FW; Roekaerts PM
J Cardiothorac Vasc Anesth; 2006 Jun; 20(3):364-70. PubMed ID: 16750737
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.
Sugiyama A; Takahara A; Hashimoto K
J Cardiovasc Pharmacol; 1999 Jul; 34(1):70-7. PubMed ID: 10413070
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics and onset of action of esmolol in anesthetized dogs.
Quon CY; Gorczynski RJ
J Pharmacol Exp Ther; 1986 Jun; 237(3):912-8. PubMed ID: 2872328
[TBL] [Abstract][Full Text] [Related]
9. Intrapericardial beta-adrenergic blockade with esmolol exerts a potent antitachycardic effect without depressing contractility.
Moreno R; Waxman S; Rowe K; Verrier RL
J Cardiovasc Pharmacol; 2000 Dec; 36(6):722-7. PubMed ID: 11117371
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenoreceptor antagonist potency and pharmacodynamics of ASL-8123, the primary acid metabolite of esmolol.
Shaffer JE; Quon CY; Gorczynski RJ
J Cardiovasc Pharmacol; 1988 Feb; 11(2):187-92. PubMed ID: 2452313
[TBL] [Abstract][Full Text] [Related]
11. [Responses of hemodynamics and splanchnic organ blood flow to esmolol during inhalation of volatile anesthetics in dogs].
Masuda R; Takeda S
Masui; 2008 Jan; 57(1):69-75. PubMed ID: 18214007
[TBL] [Abstract][Full Text] [Related]
12. Comparison of nicardipine versus esmolol in attenuating the hemodynamic responses to anesthesia emergence and extubation.
Kovac AL; Masiongale A
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):45-50. PubMed ID: 17289479
[TBL] [Abstract][Full Text] [Related]
13. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
Mio Y
Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544
[TBL] [Abstract][Full Text] [Related]
14. Systemic haemodynamic and beta-adrenoceptor antagonistic effects of bisoprolol in conscious pigs: a comparison with propranolol.
Duncker DJ; Saxena PR; Verdouw PD
Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):54-63. PubMed ID: 2895611
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary reactivity to methacholine during beta-adrenergic blockade: propranolol versus esmolol.
Tobias JD; Sauder RA; Hirshman CA
Anesthesiology; 1990 Jul; 73(1):132-6. PubMed ID: 1972872
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of dexmedetomidine and esmolol on myocardial oxygen consumption in dogs.
Willigers HM; Prinzen FW; Roekaerts PM
Eur J Anaesthesiol; 2004 Dec; 21(12):957-66. PubMed ID: 15719859
[TBL] [Abstract][Full Text] [Related]
17. Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study.
Morelli A; Singer M; Ranieri VM; D'Egidio A; Mascia L; Orecchioni A; Piscioneri F; Guarracino F; Greco E; Peruzzi M; Biondi-Zoccai G; Frati G; Romano SM
Intensive Care Med; 2016 Oct; 42(10):1528-1534. PubMed ID: 27101380
[TBL] [Abstract][Full Text] [Related]
18. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
Barbier GH; Shettigar UR; Appunn DO
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
[TBL] [Abstract][Full Text] [Related]
19. Are all effects of esmolol equally rapid in onset?
Ornstein E; Young WL; Ostapkovich N; Matteo RS; Diaz J
Anesth Analg; 1995 Aug; 81(2):297-300. PubMed ID: 7618718
[TBL] [Abstract][Full Text] [Related]
20. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
Angaran DM; Schultz NJ; Tschida VH
Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
